相关实验视频
Updated: Jan 10, 2026

05:23
Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
4.3K
CGRP和偏头痛:现实世界的洞察力和未来的治疗方向
Andrew F Russo1,2, Eric A Kaiser3
11Department of Molecular Physiology and Biophysics and Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Annual review of medicine
|November 26, 2025
概括
素基因相关 (CGRP) 抑制剂是有效的偏头痛治疗方法. 现实数据显示,这些药物是安全的,但一些不良影响正在出现,促使研究新的应用.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 向素基因相关 (CGRP) 已经彻底改变了偏头痛治疗.
- 多种CGRP抑制剂,包括单克隆抗体和小分子抗剂,已被FDA批准用于急性和预防性偏头痛治疗.
研究的目的:
- 审查正在发展的真实世界关于偏头痛CGRP抑制剂的数据.
- 讨论CGRP抑制剂的新出现的副作用和潜在的新疗法用途.
主要方法:
- 对CGRP抑制剂的真实数据的审查.
- 对安全性和有效性概况的分析.
- 关于未来应用和组合治疗的猜测.
主要成果:
- CGRP 抑制剂在治疗偏头痛方面取得了显著的成功.
- 虽然通常是安全的,但与这些抑制剂相关的一些不良影响正在变得明显.
- 现实世界的数据对于理解长期结果至关重要.
结论:
- CGRP 抑制剂代表了偏头痛管理的重大进步.
- 需要对不良影响进行持续监测.
- 未来的研究可能会探索CGRP抑制剂用于其他神经疾病和组合疗法.
相关概念视频
G Protein-coupled Receptors
16.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K
Transducer Mechanism: G Protein–Coupled Receptors
3.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.9K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K

